Stephen Schleicher, MD
Dermatology · Sugarloaf, PANPI 1861487449
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $19,945 of the $26,132 with a category attached, or 76.3%. It is spread thinly across 45 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 907 payments — averaging $28.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$5K
- AbbVie$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Johnson & Johnson$2K
- Sun Pharmaceutical Industries Inc.$2K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $9K from 39 others
Across 1,016 payments — averaging $3018.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.2M
- Sanofi US Services Inc.$450K
- Amgen$324K
- Incyte Corporation$291K
- Galderma Research & Development, LLC$119K
- Hoffmann-la Roche Limited$114K
- plus $574K from 13 others
What the payments were for
- Consulting fees$5,56821%
- Food & beverage$19,94576%
- Education$6192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,132 in reported general payments places this provider in the 90th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 14 | $107,374 |
| Dupixent PenDupilumab | 27 | $103,664 |
| Betamethasone Dipropionate | 20 | $759 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $700 |
| Triamcinolone Acetonide | 46 | $651 |
| Minocycline Hcl | 38 | $570 |
| Clobetasol Propionate | 16 | $397 |
| Ketoconazole | 12 | $197 |
| Imiquimod | 13 | $154 |
| Hydroxyzine Hcl | 13 | $95 |
| Hydrocortisone | 18 | $81 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sugarloaf
- Richard CordovaSugarloaf$39K
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.